France · Source-listed medicine information

France / CIS 68225352

BICAVERA 1,5 % Glucose, 1,75 mmol/L Calcium, solution pour dialyse péritonéale

solution et solution pour dialyse péritonéale · intrapéritonéale

Directory source checks passedOriginal source language: French

Source data retrieved: 2026-09-17. Clinical review is not yet available.

Formsolution et solution pour dialyse péritonéale
Routeintrapéritonéale
Ingredient entries6
CountryFrance

Product identity

At a glance

Authorisation holder
FRESENIUS MEDICAL CARE DEUTSCHLAND (ALLEMAGNE)
Authorisation status
Autorisation active
Market status
Commercialisée
Country
France
Source reference
CIS 68225352

Reported market status does not confirm current pharmacy stock.

From the official composition record

Ingredients & strength

Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.

Source composition entries for BICAVERA 1,5 % Glucose, 1,75 mmol/L Calcium, solution pour dialyse péritonéale
IngredientStrength / referenceSource role
CHLORURE DE CALCIUM DIHYDRATÉsolution acide0,5145 g1000 ml de solution acideSAGroup 3
GLUCOSEsolution acide30 g1000 ml de solution alcalineFTGroup 5
CHLORURE DE SODIUMsolution acide11,57 g1000 ml de solution acideSAGroup 2
CHLORURE DE MAGNÉSIUM HEXAHYDRATÉsolution acide0,2033 g1000 ml de solution acideSAGroup 4
GLUCOSE MONOHYDRATÉsolution acide33 g1000 ml de solution acideSAGroup 5
BICARBONATE DE SODIUMsolution alcaline5,880 g1000 ml de solution alcalineSAGroup 13

Pack references

Presentations (4)

2 poche(s) bicompartimenté(e)(s)/à 2 compartiments polyoléfine suremballée(s)/surpochée(s) de 5000 ml avec système sleepsafe

CIP13 3400930073087

Présentation active · Déclaration de commercialisation
4 poche(s) bicompartimenté(e)(s)/à 2 compartiments polyoléfine suremballée(s)/surpochée(s) de 2000 ml avec système staysafe

CIP13 3400935852021

Présentation active · Déclaration de commercialisation
4 poche(s) bicompartimenté(e)(s)/à 2 compartiments polyoléfine suremballée(s)/surpochée(s) de 2500 ml avec système staysafe

CIP13 3400935852199

Présentation active · Déclaration de commercialisation
4 poche(s) bicompartimenté(e)(s)/à 2 compartiments polyoléfine suremballée(s)/surpochée(s) de 3000 ml avec système sleepsafe

CIP13 3400936297210

Présentation active · Déclaration de commercialisation

From the French medicines authority

Official documents

The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.

Open the official product entryBDPM · CIS 68225352 · Opens in a new tab

Check the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.

Where this information comes from

Sources & dates

Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.

Source files and their retrieval dates
Source fileRetrievedSource file modified
fr_products.txtNot supplied
fr_composition.txtNot supplied
fr_packs.txtNot supplied

Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.

Our sources and review process →